Yes, if tirzepatide remains ineffective after optimization of dose, adherence, and lifestyle factors, switching to alternative GLP-1 receptor agonists like semaglutide or adding complementary diabetes medications may be appropriate
For individuals prescribed glucagon-like peptide-1 (GLP-1) receptor agonists such as semaglutide (Ozempic, Wegovy, Rybelsus) or dulaglutide (Trulicity), understanding magnesium's role in metabolic health is relevant
However, the slower tirzepatide titration may improve tolerability by allowing more gradual adaptation
Florian S, Krehl S, Loewinger M, Kipp A, Banning A, Esworthy S, Chu FF, Brigelius-Flohe R
PF4 is a cytokine that is specifically released from alpha-granules of activated platelets 27